Ally Bridge Group

Ally Bridge Group as of Dec. 31, 2025

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 16 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Call Option (REPL) 12.2 $12M 1.2M 9.72
Edgewise Therapeutics (EWTX) 11.5 $11M 445k 24.82
Abivax Sa Sponsored Ads (ABVX) 9.8 $9.4M 70k 134.85
Soleno Therapeutics (SLNO) 8.1 $7.8M 168k 46.30
Compass Pathways Sponsored Ads Call Option (CMPS) 7.9 $7.6M 1.1M 6.90
Atai Beckley Nv SHS 7.3 $7.0M 1.7M 4.09
Inventiva Sa Ads (IVA) 7.3 $7.0M 1.5M 4.65
Minerva Neurosciences Com New (NERV) 6.9 $6.7M 1.7M 4.02
Praxis Precision Medicines I Com New (PRAX) 6.1 $5.9M 20k 294.74
Taysha Gene Therapies Com Shs (TSHA) 5.5 $5.3M 957k 5.50
Uniqure Nv SHS Call Option (QURE) 5.0 $4.8M 200k 23.93
Eupraxia Pharmaceuticals (EPRX) 3.1 $3.0M 398k 7.55
Ovid Therapeutics (OVID) 3.0 $2.9M 1.8M 1.63
Solid Biosciences Com New (SLDB) 2.4 $2.3M 414k 5.64
Aadi Bioscience (WHWK) 2.1 $2.0M 818k 2.42
Promis Neurosciences Com Shs (PMN) 1.8 $1.7M 249k 6.83